Maricic, Michael
New and emerging treatments for osteoporosis. [electronic resource]
- Current opinion in rheumatology Jul 2007
- 364-9 p. digital
Publication Type: Journal Article; Review
1040-8711
10.1097/BOR.0b013e328172dc1a doi
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
Bone Density--drug effects
Bone Density Conservation Agents--adverse effects
Clinical Trials, Phase III as Topic
Denosumab
Diphosphonates--adverse effects
Drug Administration Routes
Drug Administration Schedule
Female
Humans
Ibandronic Acid
Imidazoles--adverse effects
Osteoporosis, Postmenopausal--drug therapy
Patient Compliance
RANK Ligand
Zoledronic Acid